Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma.

Ranjan A, Iyer SV, Ward C, Link T, Diaz FJ, Dhar A, Tawfik OW, Weinman SA, Azuma Y, Izumi T, Iwakuma T.

Oncotarget. 2018 Apr 20;9(30):21429-21443. doi: 10.18632/oncotarget.25117. eCollection 2018 Apr 20.

2.

Emerging Non-Canonical Functions and Regulation of p53.

Ranjan A, Iwakuma T.

Int J Mol Sci. 2018 Mar 28;19(4). pii: E1015. doi: 10.3390/ijms19041015.

3.

Unsaturated fatty acids regulate stemness of ovarian cancer cells through NF-κB.

Parrales A, Ranjan A, Iwakuma T.

Stem Cell Investig. 2017 Jun 3;4:49. doi: 10.21037/sci.2017.05.07. eCollection 2017. No abstract available.

4.

Akt1/NFκB signaling pathway activation by a small molecule DMA confers radioprotection to intestinal epithelium in xenograft model.

Tiwari V, Kamran MZ, Ranjan A, Nimesh H, Singh M, Tandon V.

Free Radic Biol Med. 2017 Jul;108:564-574. doi: 10.1016/j.freeradbiomed.2017.04.029. Epub 2017 Apr 21.

PMID:
28435051
5.

Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy.

Ranjan A, Iyer SV, Iwakuma T.

Cell Cycle. 2017 May 19;16(10):903-904. doi: 10.1080/15384101.2017.1308153. Epub 2017 Mar 29. No abstract available.

6.

Non-Canonical Cell Death Induced by p53.

Ranjan A, Iwakuma T.

Int J Mol Sci. 2016 Dec 9;17(12). pii: E2068. Review.

7.

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression.

Iyer SV, Ranjan A, Elias HK, Parrales A, Sasaki H, Roy BC, Umar S, Tawfik OW, Iwakuma T.

Nat Commun. 2016 Nov 25;7:13561. doi: 10.1038/ncomms13561.

8.

DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.

Parrales A, Ranjan A, Iyer SV, Padhye S, Weir SJ, Roy A, Iwakuma T.

Nat Cell Biol. 2016 Nov;18(11):1233-1243. doi: 10.1038/ncb3427. Epub 2016 Oct 24.

9.

Radioprotective Agents: Strategies and Translational Advances.

Kamran MZ, Ranjan A, Kaur N, Sur S, Tandon V.

Med Res Rev. 2016 May;36(3):461-93. doi: 10.1002/med.21386. Epub 2016 Jan 25. Review.

PMID:
26807693
10.

Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis.

Ranjan A, Bera K, Iwakuma T.

Hepatoma Res. 2016;2:114-121. doi: 10.20517/2394-5079.2015.67. Epub 2016 May 6.

11.

MTBP inhibits migration and metastasis of hepatocellular carcinoma.

Bi Q, Ranjan A, Fan R, Agarwal N, Welch DR, Weinman SA, Ding J, Iwakuma T.

Clin Exp Metastasis. 2015 Apr;32(4):301-11. doi: 10.1007/s10585-015-9706-5. Epub 2015 Mar 11.

12.

3,4-Dimethoxyphenyl bis-benzimidazole derivative, mitigates radiation-induced DNA damage.

Ranjan A, Kaur N, Tiwari V, Singh Y, Chaturvedi MM, Tandon V.

Radiat Res. 2013 Jun;179(6):647-62. doi: 10.1667/RR3246.1. Epub 2013 May 3.

PMID:
23642081
13.

Inhibition of 5'-UTR RNA conformational switching in HIV-1 using antisense PNAs.

Parkash B, Ranjan A, Tiwari V, Gupta SK, Kaur N, Tandon V.

PLoS One. 2012;7(11):e49310. doi: 10.1371/journal.pone.0049310. Epub 2012 Nov 12.

14.

Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme.

Singh N, Ranjan A, Sur S, Chandra R, Tandon V.

J Biosci. 2012 Jul;37(3):493-502.

PMID:
22750986
15.

DMA, a bisbenzimidazole, offers radioprotection by promoting NFκB transactivation through NIK/IKK in human glioma cells.

Kaur N, Ranjan A, Tiwari V, Aneja R, Tandon V.

PLoS One. 2012;7(6):e39426. doi: 10.1371/journal.pone.0039426. Epub 2012 Jun 22.

Supplemental Content

Loading ...
Support Center